Triterpene derivatives and endothelin-receptor antagonists conta

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbonate esters

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

560 23, 560 51, 562 37, 562453, C07C 6996, C07C22934

Patent

active

055875050

ABSTRACT:
Triterpene derivatives of the formula (I): ##STR1## wherein R.sup.1 is hydrogen or metabolic ester residue; and R.sup.2 is hydrogen or --R.sup.3 -R.sup.4 wherein R.sup.3 is --SO.sub.3 --, --CH.sub.2 COO--, --COCOO--, or --COR.sup.5 COO-- (R.sup.5 is lower alkylene or lower alkenylene), and R.sup.4 is hydrogen or metabolic ester residue or a pharmaceutically acceptable salt thereof, which have anti-endothelin activities and are useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin.

REFERENCES:
Georgarakis, et al., Helv. Chim. Acta., 62(1), 234-70 1979.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Triterpene derivatives and endothelin-receptor antagonists conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triterpene derivatives and endothelin-receptor antagonists conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triterpene derivatives and endothelin-receptor antagonists conta will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1179696

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.